Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Clinical trial NCT01402089 · COMPLETED

Trial details

NCT number: NCT01402089
Sponsor: Markus Joerger
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non Small-cell Lung Cancer Renal-cell Cancer Gastrointestinal Stroma Tumor

Start date: 2012-01-01
Primary completion: 2015-07-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.